Multi-agent note output

LRCX

Equity research — LRCX (as of 2026-05-08)

Updated May 8, 2026

Agent consensus

SELL

Coverage

LRCX

Freshness

11 days ago

Market chart

Price context alongside the research narrative.

Desk briefing

Here is the analysis of LRCX (Lam Research Corporation) as of May 8, 2026.

Full research note

Presentation-ready note with specialist analyst agents, bull and bear agent debate, trader agent synthesis, risk challenge, and portfolio sign-off.

50 min readInstitutional format

WebserviceX.NET Research Desk

LRCX Equity Research Note

Published May 8, 2026 · Desk view SELL

Summary

Here is the analysis of LRCX (Lam Research Corporation) as of May 8, 2026.

Bias

SELL

Horizon

Short to medium term

Key risk

No position is risk-free. The semi capex cycle can turn faster than expected if AI investment disappoints or export controls tighten. Goldman Sachs flags the AI payoff as the “biggest question,” and WSJ draws comparisons to the 2000 tech bubble. If sentiment shifts, a stock with a beta of 1.82 and a 55.6x trailing P/E could correct sharply. But here’s the key: the forward P/E at 37.2x is already pricing in some deceleration, and the PEG of 1.72 says the growth is still cheap relative to the multiple. The risk is real, but it’s a risk of timing, not of destruction of the business case. Lam’s revenue is hitting new highs, margins are best-in-class, and the AI-driven WFE super-cycle has years left to run.

Catalyst watch

Analyst tone is cautiously positive — B. Riley's raised target and Buy rating (carried into early May) provide the most concrete LRCX-specific signal.